Suppr超能文献

达托霉素(LY146032)治疗实验性肠球菌心内膜炎。

Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.

作者信息

Bush L M, Boscia J A, Kaye D

机构信息

Department of Medicine, Medical College of Pennsylvania, Philadelphia 19129.

出版信息

Antimicrob Agents Chemother. 1988 Jun;32(6):877-81. doi: 10.1128/AAC.32.6.877.

Abstract

This study compared daptomycin (LY146032) with penicillin G procaine and vancomycin without and with gentamicin for treatment of experimental enterococcal endocarditis. The strain of Streptococcus (Enterococcus) faecalis used in this study was killed by daptomycin in vitro in broth but not in serum. In rabbits treated for 3 days, daptomycin significantly reduced bacterial counts of vegetations compared with no therapy but was significantly less effective than penicillin G procaine or vancomycin. Daptomycin-gentamicin significantly reduced bacterial counts of vegetations compared with daptomycin alone but was significantly less effective than vancomycin plus gentamicin. The efficacy of daptomycin-gentamicin did not differ significantly from that of penicillin G procaine-gentamicin. The lack of enterococcal killing by daptomycin alone in serum and in experimental endocarditis is probably related to the high protein binding of the agent.

摘要

本研究比较了达托霉素(LY146032)与普鲁卡因青霉素G及万古霉素(分别联合或不联合庆大霉素)治疗实验性肠球菌心内膜炎的效果。本研究中使用的粪肠球菌菌株在体外肉汤中可被达托霉素杀死,但在血清中则不然。在接受3天治疗的兔中,与未治疗相比,达托霉素显著降低了赘生物的细菌数量,但效果明显不如普鲁卡因青霉素G或万古霉素。与单用达托霉素相比,达托霉素-庆大霉素显著降低了赘生物的细菌数量,但效果明显不如万古霉素加庆大霉素。达托霉素-庆大霉素的疗效与普鲁卡因青霉素G-庆大霉素的疗效无显著差异。达托霉素在血清中和实验性心内膜炎中单独使用时无法杀灭肠球菌,这可能与该药物的高蛋白结合率有关。

相似文献

1
Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.
Antimicrob Agents Chemother. 1988 Jun;32(6):877-81. doi: 10.1128/AAC.32.6.877.
3
Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits.
Antimicrob Agents Chemother. 1989 Sep;33(9):1522-5. doi: 10.1128/AAC.33.9.1522.
4
LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci.
Antimicrob Agents Chemother. 1988 Jan;32(1):141-3. doi: 10.1128/AAC.32.1.141.
5
Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
Antimicrob Agents Chemother. 1987 Aug;31(8):1199-203. doi: 10.1128/AAC.31.8.1199.
7
Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.
Antimicrob Agents Chemother. 1985 Feb;27(2):224-6. doi: 10.1128/AAC.27.2.224.
9
Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
Antimicrob Agents Chemother. 1985 Jan;27(1):135-6. doi: 10.1128/AAC.27.1.135.
10
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11.

引用本文的文献

2
High-Dose Daptomycin and Clinical Applications.
Ann Pharmacother. 2021 Nov;55(11):1363-1378. doi: 10.1177/1060028021991943. Epub 2021 Feb 4.
3
Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.
Infection. 2016 Jun;44(3):273-81. doi: 10.1007/s15010-015-0836-0. Epub 2015 Sep 1.
5
Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.
Clin Infect Dis. 2011 Jan 15;52(2):228-34. doi: 10.1093/cid/ciq113.
6
Daptomycin: a cyclic lipopeptide antimicrobial agent.
Clin Ther. 2004 Nov;26(11):1728-57. doi: 10.1016/j.clinthera.2004.11.014.
8
Current perspectives on glycopeptide resistance.
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
9
Infections due to antibiotic-resistant gram-positive cocci.
J Gen Intern Med. 1993 Nov;8(11):626-34. doi: 10.1007/BF02599723.
10
Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits.
Antimicrob Agents Chemother. 1989 Sep;33(9):1522-5. doi: 10.1128/AAC.33.9.1522.

本文引用的文献

1
Effect of protein binding on antibiotic activity in vivo.
J Antimicrob Chemother. 1983 Mar;11(3):233-8. doi: 10.1093/jac/11.3.233.
2
High-level resistance to gentamicin in clinical isolates of enterococci.
J Infect Dis. 1983 Apr;147(4):751-7. doi: 10.1093/infdis/147.4.751.
4
Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.
Antimicrob Agents Chemother. 1973 Aug;4(2):120-4. doi: 10.1128/AAC.4.2.120.
6
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.
Ann Intern Med. 1987 May;106(5):687-91. doi: 10.7326/0003-4819-106-5-687.
8
Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.
Antimicrob Agents Chemother. 1986 Dec;30(6):861-4. doi: 10.1128/AAC.30.6.861.
9
In vitro activity of LY146032 against staphylococci, streptococci, and enterococci.
Antimicrob Agents Chemother. 1986 Nov;30(5):781-4. doi: 10.1128/AAC.30.5.781.
10
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.
Antimicrob Agents Chemother. 1986 Oct;30(4):532-5. doi: 10.1128/AAC.30.4.532.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验